Dawn Vanderhoef, PhD, DNP, PMHNP-BC, FAANP

Neurocrine Biosciences, Inc., San Diego, California

  • 1Article
  • 1.3KReads1
  • 2026Active
  • 9Collaborators

1 Read counts for articles published before 2020 may include some non-human traffic.

About

Dawn Vanderhoef, PhD, DNP, PMHNP-BC, FAANP is affiliated with Neurocrine Biosciences, Inc., San Diego, California. Dawn Vanderhoef has contributed 1 peer-reviewed article published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders in 2026. Their work focuses on Schizophrenia/Schizoaffective Disorders and Tardive Dyskinesia.

Publications

JCP
Validation for the Tardive Dyskinesia Impact Scale, a Patient-Reported Outcome Measure in Valbenazine Clinical Trials

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.